The Impact of Delayed Transition From Noninvasive to Invasive Mechanical Ventilation on Hospital Mortality in Immunocompromised Patients With Sepsis
- PMID: 39166925
- DOI: 10.1097/CCM.0000000000006400
The Impact of Delayed Transition From Noninvasive to Invasive Mechanical Ventilation on Hospital Mortality in Immunocompromised Patients With Sepsis
Abstract
Objective: To determine whether mortality differed between initial invasive mechanical ventilation (IMV) or noninvasive ventilation (NIV) followed by delayed IMV in immunocompromised patients with sepsis.
Design: Retrospective analysis using the National Data Center for Medical Service claims data in China from 2017 to 2019.
Setting: A total of 3530 hospitals across China.
Patients: A total of 36,187 adult immunocompromised patients with sepsis requiring ventilation.
Interventions: None.
Measurements and main results: The primary outcome was hospital mortality. Patients were categorized into NIV initiation or IMV initiation groups based on first ventilation. NIV patients were further divided by time to IMV transition: no transition, immediate (≤ 1 d), early (2-3 d), delayed (4-7 d), or late (≥ 8 d). Mortality was compared between groups using weighted Cox models. Over the median 9-day follow-up, mortality was similar for initial NIV versus IMV (adjusted hazard ratio [HR] 1.006; 95% CI, 0.959-1.055). However, among NIV patients, a longer time to IMV transition is associated with stepwise increases in mortality, from immediate transition (HR 1.65) to late transition (HR 2.51), compared with initial IMV. This dose-response relationship persisted across subgroups and sensitivity analyses.
Conclusions: Prolonged NIV trial before delayed IMV transition is associated with higher mortality in immunocompromised sepsis patients ultimately intubated.
Copyright © 2024 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
Conflict of interest statement
The authors have disclosed that they do not have any potential conflicts of interest.
References
-
- Azoulay E, Pickkers P, Soares M, et al.: Acute hypoxemic respiratory failure in immunocompromised patients: The Efraim multinational prospective cohort study. Intensive Care Med 2017; 43:1808–1819
-
- Frat JP, Ragot S, Girault C, et al.: Effect of non-invasive oxygenation strategies in immunocompromised patients with severe acute respiratory failure: A post-hoc analysis of a randomised trial. Lancet Respir Med 2016; 4:646–652
-
- Munshi L, Mancebo J, Brochard L: Noninvasive respiratory support for adults with acute respiratory failure. N Engl J Med 2022; 387:1688–1698
-
- Rochwerg B, Brochard L, Elliott MW, et al.: Official ERS/ATS clinical practice guidelines: Noninvasive ventilation for acute respiratory failure. Eur Respir J 2017; 50:1602426
-
- Kangelaris K, Ware L, Wang C, et al.: Timing of intubation and clinical outcomes in adults with acute respiratory distress syndrome. Crit Care Med 2016; 44:120–129
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
